CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks. Ultimately a vaccine...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) cut the top end of its sales forecast for the blockbuster eye drug Eylea, citing slower adoption by...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (SNY) released that the first patients have been dosed in a Phase 3 clinical study of...
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Friday morning that EYLEA Injection demonstrated a significantly greater improvement in mean change in best-corrected visual acuity...
Telefonica S.A. (ADR) (NYSE:TEF) declared that its plan to cut 1,600 full-time positions by 2018. The firm reported that the job reductions...